Patient-specific, 3-dimensional dosimetry in non-Hodgkin's lymphoma patients treated with 131I-anti-B1 antibody: assessment of tumor dose-response.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine

Volumn 44, Issue 2, 2003, Pages 260-268

  Sgouros, George ^a   Squeri, Shannon ^a   Ballangrud, Ase M ^a   Kolbert, Katherine S ^a   Teitcher, Jerrold B ^a   Panageas, Katherine S ^a   Finn, Ronald D ^a   Divgi, Chaitanya R ^a   Larson, Steven M ^a   Zelenetz, Andrew D ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; IODINE 131 ANTI B1 ANTIBODY; IODINE-131 ANTI-B1 ANTIBODY; MONOCLONAL ANTIBODY;

ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED RADIOTHERAPY; FEMALE; HUMAN; MALE; METHODOLOGY; MULTICENTER STUDY; NONHODGKIN LYMPHOMA; PHASE 2 CLINICAL TRIAL; RADIATION EXPOSURE; RADIATION RESPONSE; RADIOIMMUNOTHERAPY; RADIOMETRY; SCINTISCANNING; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; THREE DIMENSIONAL IMAGING; THROMBOCYTE; TREATMENT OUTCOME; VALIDATION STUDY; VASCULAR TUMOR; WHOLE BODY COUNTING;

ANTIBODIES, MONOCLONAL; ANTINEOPLASTIC AGENTS; BLOOD PLATELETS; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; HUMANS; IMAGING, THREE-DIMENSIONAL; LYMPHOMA, NON-HODGKIN; MALE; RADIOIMMUNOTHERAPY; RADIOMETRY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME; VASCULAR NEOPLASMS; WHOLE-BODY COUNTING;

EID: 0037317431     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)